Somatic Mutation
15
5
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (15)
Somatic Mosaicism in Twins Discordant for Childhood Cancer
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
iSITE: Investigation of Somatic Alterations in Tumours of the Eye
Linking Somatic Mutation Rate With Baseline Exposure in East Palestine
Molecular Diagnosis of Systemic Autoinflammatory Diseases
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
SMS - Study of Somatic Mutations Using Genome Sequencing
Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project
SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues
Somatic Mutation in Chronic Liver Disease
Exploring the Landscape of Somatic Mutations in Human Tissue
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment